TreeWAS – Variant ID: rs75518588

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D12 Benign neoplasm of colon, rectum, anus and anal canal	1.000	0.000	0.000
D12.4 Descending colon	1.000	0.000	0.000
D12.8 Rectum	0.997	0.003	0.000
D12.2 Ascending colon	0.992	0.008	0.000
D12.3 Transverse colon	0.990	0.010	0.000
D12.5 Sigmoid colon	0.988	0.012	0.000
D12.6 Colon, unspecified	0.907	0.093	0.000
D12.0 Caecum	0.896	0.104	0.000
D12.7 Rectosigmoid junction	0.824	0.176	0.000
D12.1 Appendix	0.691	0.309	0.000
D12.9 Anus and anal canal	0.435	0.564	0.001
Z90.1 Acquired absence of breast(s)	0.067	0.933	0.000
J31.0 Chronic rhinitis	0.000	0.969	0.031
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria	0.000	0.969	0.031
C34.9 Bronchus or lung, unspecified	0.030	0.970	0.000
C34 Malignant neoplasm of bronchus and lung	0.029	0.971	0.000
C34.3 Lower lobe, bronchus or lung	0.028	0.972	0.000
T45.0 Antiallergic and antiemetic drugs	0.027	0.973	0.000
C34.0 Main bronchus	0.027	0.973	0.000
C34.1 Upper lobe, bronchus or lung	0.026	0.974	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.025	0.975	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.025	0.975	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.025	0.975	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.023	0.977	0.000
C34.8 Overlapping lesion of bronchus and lung	0.022	0.977	0.000
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium	0.000	0.978	0.022
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.022	0.978	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.021	0.979	0.000
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria	0.000	0.979	0.021
T45.5 Anticoagulants	0.021	0.979	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.021	0.979	0.000
T46.1 Calcium-channel blockers	0.020	0.979	0.000
O14.9 Preeclampsia, unspecified	0.000	0.980	0.020
T50.4 Drugs affecting uric acid metabolism	0.020	0.980	0.000
Z90.2 Acquired absence of lung [part of]	0.019	0.981	0.000
T47.0 Histamine H(2)-receptor antagonists	0.019	0.981	0.000
Z90.5 Acquired absence of kidney	0.019	0.981	0.000
T45.2 Vitamins, not elsewhere classified	0.019	0.981	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.019	0.981	0.000
T50.1 Loop [high-ceiling] diuretics	0.019	0.981	0.000
M47.86 Other spondylosis (Lumbar region)	0.000	0.981	0.019
T45.9 Primarily systemic and haematological agent, unspecified	0.018	0.982	0.000
T45.8 Other primarily systemic and haematological agents	0.018	0.982	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.018	0.982	0.000
T45.6 Fibrinolysis-affecting drugs	0.018	0.982	0.000
T45.4 Iron and its compounds	0.018	0.982	0.000
T45.3 Enzymes, not elsewhere classified	0.018	0.982	0.000
O14.1 Severe preeclampsia	0.000	0.982	0.018
T36 Poisoning by systemic antibiotics	0.018	0.982	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.018	0.982	0.000
O12 Gestational [pregnancy-induced] oedema and proteinuria without hypertension	0.000	0.982	0.018
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.018	0.982	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.018	0.982	0.000
T46.7 Peripheral vasodilators	0.018	0.982	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.018	0.982	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.018	0.982	0.000
T47.4 Other laxatives	0.018	0.982	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.018	0.982	0.000
Z90 Acquired absence of organs, not elsewhere classified	0.018	0.982	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.017	0.983	0.000
C34.2 Middle lobe, bronchus or lung	0.017	0.983	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.017	0.983	0.000
T50.8 Diagnostic agents	0.017	0.983	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.016	0.983	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.016	0.983	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.016	0.983	0.000
O10 Pre-existing hypertension complicating pregnancy, childbirth and the puerperium	0.000	0.984	0.016
O15 Eclampsia	0.000	0.984	0.016
O11 Pre-existing hypertensive disorder with superimposed proteinuria	0.000	0.984	0.016
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.016	0.984	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.016	0.984	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.016	0.984	0.000
T47.7 Emetics	0.016	0.984	0.000
T47.6 Antidiarrhoeal drugs	0.016	0.984	0.000
T47.5 Digestants	0.016	0.984	0.000
T47.3 Saline and osmotic laxatives	0.016	0.984	0.000
T47.2 Stimulant laxatives	0.016	0.984	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.016	0.984	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.016	0.984	0.000
T50.7 Analeptics and opioid receptor antagonists	0.015	0.984	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.015	0.984	0.000
T50.5 Appetite depressants	0.015	0.984	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.015	0.984	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.015	0.984	0.000
T50.0 Mineralocorticoids and their antagonists	0.015	0.984	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.015	0.984	0.000
O14.2 HELLP syndrome	0.000	0.985	0.015
O12.0 Gestational oedema	0.000	0.985	0.015
T36.0 Penicillins	0.015	0.985	0.000
J34.3 Hypertrophy of nasal turbinates	0.000	0.985	0.015
M06.9 Rheumatoid arthritis, unspecified	0.014	0.986	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.014	0.986	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.014	0.986	0.000
O14.0 Moderate preeclampsia	0.000	0.986	0.014
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.013	0.986	0.000
T36.9 Systemic antibiotic, unspecified	0.013	0.987	0.000
T36.8 Other systemic antibiotics	0.013	0.987	0.000
T36.7 Antifungal antibiotics, systemically used	0.013	0.987	0.000
T36.6 Rifamycins	0.013	0.987	0.000
T36.5 Aminoglycosides	0.013	0.987	0.000
T36.4 Tetracyclines	0.013	0.987	0.000
T36.3 Macrolides	0.013	0.987	0.000
T36.2 Chloramphenicol group	0.013	0.987	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.013	0.987	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.013	0.987	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.013	0.987	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.013	0.987	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.013	0.987	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.013	0.987	0.000
T44.0 Anticholinesterase agents	0.013	0.987	0.000
O12.2 Gestational oedema with proteinuria	0.000	0.987	0.013
O12.1 Gestational proteinuria	0.000	0.987	0.013
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.012	0.988	0.000
T41.5 Therapeutic gases	0.012	0.988	0.000
T41.4 Anaesthetic, unspecified	0.012	0.988	0.000
T41.3 Local anaesthetics	0.012	0.988	0.000
T41.2 Other and unspecified general anaesthetics	0.012	0.988	0.000
T41.1 Intravenous anaesthetics	0.012	0.988	0.000
T41.0 Inhaled anaesthetics	0.012	0.988	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.012	0.988	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.012	0.988	0.000
T48.5 Anti-common-cold drugs	0.012	0.988	0.000
T48.4 Expectorants	0.012	0.988	0.000
T48.3 Antitussives	0.012	0.988	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.012	0.988	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.012	0.988	0.000
T48.0 Oxytocic drugs	0.012	0.988	0.000
T49.9 Topical agent, unspecified	0.012	0.988	0.000
T49.8 Other topical agents	0.012	0.988	0.000
T49.7 Dental drugs, topically applied	0.012	0.988	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.012	0.988	0.000
T49.5 Ophthalmological drugs and preparations	0.012	0.988	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.012	0.988	0.000
T49.3 Emollients, demulcents and protectants	0.012	0.988	0.000
T49.2 Local astringents and local detergents	0.012	0.988	0.000
T49.1 Antipruritics	0.012	0.988	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.012	0.988	0.000
O10.0 Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium	0.000	0.988	0.012
Q21.1 Atrial septal defect	0.012	0.988	0.000
O10.9 Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium	0.000	0.988	0.012
O10.4 Pre-existing secondary hypertension complicating pregnancy, childbirth and the puerperium	0.000	0.988	0.012
O10.3 Pre-existing hypertensive heart and renal disease complicating pregnancy, childbirth and the puerperium	0.000	0.988	0.012
O10.2 Pre-existing hypertensive renal disease complicating pregnancy, childbirth and the puerperium	0.000	0.988	0.012
O10.1 Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium	0.000	0.988	0.012
O15.9 Eclampsia, unspecified as to time period	0.000	0.988	0.012
O15.2 Eclampsia in the puerperium	0.000	0.988	0.012
O15.1 Eclampsia in labour	0.000	0.988	0.012
O15.0 Eclampsia in pregnancy	0.000	0.988	0.012
M06.98 Rheumatoid arthritis, unspecified (Other)	0.012	0.988	0.000
T38.1 Thyroid hormones and substitutes	0.011	0.988	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.011	0.988	0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.011	0.988	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.011	0.988	0.000
T37.5 Antiviral drugs	0.011	0.988	0.000
T37.4 Anthelminthics	0.011	0.988	0.000
T37.3 Other antiprotozoal drugs	0.011	0.988	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.011	0.988	0.000
T37.1 Antimycobacterial drugs	0.011	0.988	0.000
T37.0 Sulphonamides	0.011	0.988	0.000
T38.9 Other and unspecified hormone antagonists	0.011	0.989	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.011	0.989	0.000
T38.7 Androgens and anabolic congeners	0.011	0.989	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.011	0.989	0.000
T38.5 Other oestrogens and progestogens	0.011	0.989	0.000
T38.4 Oral contraceptives	0.011	0.989	0.000
T38.2 Antithyroid drugs	0.011	0.989	0.000
T38.0 Glucocorticoids and synthetic analogues	0.011	0.989	0.000
O16 Unspecified maternal hypertension	0.000	0.989	0.011
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.011	0.989	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.011	0.989	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.011	0.989	0.000
J31 Chronic rhinitis, nasopharyngitis and pharyngitis	0.000	0.989	0.011
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.011	0.989	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.010	0.989	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.010	0.990	0.000
Q21 Congenital malformations of cardiac septa	0.010	0.990	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.010	0.990	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.010	0.990	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.010	0.990	0.000
Z90.8 Acquired absence of other organs	0.010	0.990	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.010	0.990	0.000
T39.0 Salicylates	0.009	0.990	0.000
Q23 Congenital malformations of aortic and mitral valves	0.009	0.991	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.009	0.991	0.000
Q24 Other congenital malformations of heart	0.009	0.991	0.000
Q23.1 Congenital insufficiency of aortic valve	0.009	0.991	0.000
Q25 Congenital malformations of great arteries	0.009	0.991	0.000
C37 Malignant neoplasm of thymus	0.009	0.991	0.000
J31.1 Chronic nasopharyngitis	0.000	0.991	0.009
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.009	0.991	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.008	0.992	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.008	0.992	0.000
T39.4 Antirheumatics, not elsewhere classified	0.008	0.992	0.000
T39.2 Pyrazolone derivatives	0.008	0.992	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.008	0.992	0.000
Q27 Other congenital malformations of peripheral vascular system	0.008	0.992	0.000
Q24.8 Other specified congenital malformations of heart	0.008	0.992	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.008	0.992	0.000
C31 Malignant neoplasm of accessory sinuses	0.008	0.992	0.000
C33 Malignant neoplasm of trachea	0.008	0.992	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.008	0.992	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.008	0.992	0.000
Z90.0 Acquired absence of part of head and neck	0.008	0.992	0.000
Q21.8 Other congenital malformations of cardiac septa	0.007	0.992	0.000
Q21.4 Aortopulmonary septal defect	0.007	0.992	0.000
Q21.2 Atrioventricular septal defect	0.007	0.992	0.000
Q25.4 Other congenital malformations of aorta	0.008	0.992	0.000
Q25.6 Stenosis of pulmonary artery	0.008	0.992	0.000
Q26 Congenital malformations of great veins	0.007	0.992	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.007	0.992	0.000
Z12.1 Special screening examination for neoplasm of intestinal tract	0.008	0.992	0.000
Q24.5 Malformation of coronary vessels	0.007	0.992	0.000
Q21.3 Tetralogy of Fallot	0.007	0.993	0.000
Q25.0 Patent ductus arteriosus	0.007	0.993	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.007	0.993	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.007	0.993	0.000
T42.3 Barbiturates	0.007	0.993	0.000
T42.2 Succinimides and oxazolidinediones	0.007	0.993	0.000
T42.1 Iminostilbenes	0.007	0.993	0.000
Q21.9 Congenital malformation of cardiac septum, unspecified	0.007	0.993	0.000
Q24.0 Dextrocardia	0.007	0.993	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.007	0.993	0.000
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.007	0.993	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.007	0.993	0.000
Q23.4 Hypoplastic left heart syndrome	0.007	0.993	0.000
Q23.3 Congenital mitral insufficiency	0.007	0.993	0.000
Q23.2 Congenital mitral stenosis	0.007	0.993	0.000
C38.4 Pleura	0.007	0.993	0.000
Q27.8 Other specified congenital malformations of peripheral vascular system	0.007	0.993	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.007	0.993	0.000
T40.8 Lysergide [LSD]	0.007	0.993	0.000
T40.7 Cannabis (derivatives)	0.007	0.993	0.000
T40.5 Cocaine	0.007	0.993	0.000
T40.3 Methadone	0.007	0.993	0.000
T40.1 Heroin	0.007	0.993	0.000
T40.0 Opium	0.007	0.993	0.000
Q24.6 Congenital heart block	0.007	0.993	0.000
Q24.4 Congenital subaortic stenosis	0.007	0.993	0.000
Q24.3 Pulmonary infundibular stenosis	0.007	0.993	0.000
Q24.2 Cor triatriatum	0.007	0.993	0.000
Q24.1 Levocardia	0.007	0.993	0.000
M71.26 Synovial cyst of popliteal space [Baker]-Lower Leg	0.007	0.993	0.000
Q25.9 Congenital malformation of great arteries, unspecified	0.007	0.993	0.000
Q25.8 Other congenital malformations of great arteries	0.007	0.993	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.007	0.993	0.000
Q25.5 Atresia of pulmonary artery	0.007	0.993	0.000
Q25.3 Stenosis of aorta	0.007	0.993	0.000
Q25.2 Atresia of aorta	0.007	0.993	0.000
Q28 Other congenital malformations of circulatory system	0.007	0.993	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.007	0.993	0.000
Q25.1 Coarctation of aorta	0.006	0.994	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.006	0.994	0.000
C38.3 Mediastinum, part unspecified	0.006	0.994	0.000
C38.2 Posterior mediastinum	0.006	0.994	0.000
C38.1 Anterior mediastinum	0.006	0.994	0.000
C38.0 Heart	0.006	0.994	0.000
T42.0 Hydantoin derivatives	0.006	0.994	0.000
Q23.0 Congenital stenosis of aortic valve	0.006	0.994	0.000
Q22.1 Congenital pulmonary valve stenosis	0.006	0.994	0.000
Z96.1 Presence of intraocular lens	0.006	0.994	0.000
Q21.0 Ventricular septal defect	0.006	0.994	0.000
Q27.3 Peripheral arteriovenous malformation	0.006	0.994	0.000
H04.2 Epiphora	0.000	0.994	0.006
T40.4 Other synthetic narcotics	0.006	0.994	0.000
Q27.4 Congenital phlebectasia	0.006	0.994	0.000
Q27.2 Other congenital malformations of renal artery	0.006	0.994	0.000
Q27.1 Congenital renal artery stenosis	0.006	0.994	0.000
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.006	0.994	0.000
C90.2 Plasmacytoma, extramedullary	0.006	0.994	0.000
K62.0 Anal polyp	0.006	0.994	0.000
T43.9 Psychotropic drug, unspecified	0.006	0.994	0.000
C31.9 Accessory sinus, unspecified	0.006	0.994	0.000
C31.8 Overlapping lesion of accessory sinuses	0.006	0.994	0.000
C31.3 Sphenoidal sinus	0.006	0.994	0.000
C31.2 Frontal sinus	0.006	0.994	0.000
C31.1 Ethmoidal sinus	0.006	0.994	0.000
C31.0 Maxillary sinus	0.006	0.994	0.000
C39.9 Ill-defined sites within the respiratory system	0.006	0.994	0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.006	0.994	0.000
C39.0 Upper respiratory tract, part unspecified	0.006	0.994	0.000
Q22.9 Congenital malformation of tricuspid valve, unspecified	0.006	0.994	0.000
Q22.8 Other congenital malformations of tricuspid valve	0.006	0.994	0.000
Q22.6 Hypoplastic right heart syndrome	0.006	0.994	0.000
Q22.5 Ebstein's anomaly	0.006	0.994	0.000
Q22.4 Congenital tricuspid stenosis	0.006	0.994	0.000
Q22.3 Other congenital malformations of pulmonary valve	0.006	0.994	0.000
Q22.2 Congenital pulmonary valve insufficiency	0.006	0.994	0.000
Q22.0 Pulmonary valve atresia	0.006	0.994	0.000
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.006	0.994	0.000
C32 Malignant neoplasm of larynx	0.006	0.994	0.000
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified	0.005	0.994	0.000
Q20.8 Other congenital malformations of cardiac chambers and connexions	0.005	0.994	0.000
Q20.6 Isomerism of atrial appendages	0.005	0.994	0.000
Q20.5 Discordant atrioventricular connexion	0.005	0.994	0.000
Q20.4 Double inlet ventricle	0.005	0.994	0.000
Q20.3 Discordant ventriculoarterial connexion	0.005	0.994	0.000
Q20.2 Double outlet left ventricle	0.005	0.994	0.000
Q20.1 Double outlet right ventricle	0.005	0.994	0.000
Q20.0 Common arterial trunk	0.005	0.994	0.000
Q26.9 Congenital malformation of great vein, unspecified	0.005	0.994	0.000
Q26.8 Other congenital malformations of great veins	0.005	0.994	0.000
Q26.6 Portal vein-hepatic artery fistula	0.005	0.994	0.000
Q26.5 Anomalous portal venous connexion	0.005	0.994	0.000
Q26.4 Anomalous pulmonary venous connexion, unspecified	0.005	0.994	0.000
Q26.3 Partial anomalous pulmonary venous connexion	0.005	0.994	0.000
Q26.2 Total anomalous pulmonary venous connexion	0.005	0.994	0.000
Q26.1 Persistent left superior vena cava	0.005	0.994	0.000
Q26.0 Congenital stenosis of vena cava	0.005	0.994	0.000
C18.0 Caecum	0.006	0.994	0.000
Z90.6 Acquired absence of other parts of urinary tract	0.005	0.994	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.005	0.995	0.000
J98.4 Other disorders of lung	0.005	0.995	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.005	0.995	0.000
C30.1 Middle ear	0.005	0.995	0.000
J31.2 Chronic pharyngitis	0.000	0.995	0.005
J34.2 Deviated nasal septum	0.000	0.995	0.005
Z03.5 Observation for other suspected cardiovascular diseases	0.000	0.995	0.005
T43.6 Psychostimulants with abuse potential	0.005	0.995	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.005	0.995	0.000
R21 Rash and other nonspecific skin eruption	0.005	0.995	0.000
Q28.9 Congenital malformation of circulatory system, unspecified	0.005	0.995	0.000
Q28.8 Other specified congenital malformations of circulatory system	0.005	0.995	0.000
Q28.3 Other malformations of cerebral vessels	0.005	0.995	0.000
Q28.1 Other malformations of precerebral vessels	0.005	0.995	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.005	0.995	0.000
T40.6 Other and unspecified narcotics	0.005	0.995	0.000
T40.2 Other opioids	0.005	0.995	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.005	0.995	0.000
M77.02 Medial epicondylitis (Upper arm)	0.005	0.995	0.000
M71.2 Synovial cyst of popliteal space [Baker]	0.005	0.995	0.000
J34 Other disorders of nose and nasal sinuses	0.000	0.995	0.005
T42.4 Benzodiazepines	0.005	0.995	0.000
C90.0 Multiple myeloma	0.004	0.995	0.000
M06 Other rheumatoid arthritis	0.004	0.995	0.000
H53.9 Visual disturbance, unspecified	0.004	0.996	0.000
T43.2 Other and unspecified antidepressants	0.004	0.996	0.000
C32.8 Overlapping lesion of larynx	0.004	0.996	0.000
C32.3 Laryngeal cartilage	0.004	0.996	0.000
C32.2 Subglottis	0.004	0.996	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.004	0.996	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.004	0.996	0.000
C30.0 Nasal cavity	0.004	0.996	0.000
C32.9 Larynx, unspecified	0.004	0.996	0.000
K63.5 Polyp of colon	0.004	0.996	0.000
Q28.2 Arteriovenous malformation of cerebral vessels	0.004	0.996	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.004	0.996	0.000
F31.9 Bipolar affective disorder, unspecified	0.000	0.996	0.004
D37.7 Other digestive organs	0.000	0.996	0.004
T43.5 Other and unspecified antipsychotics and neuroleptics	0.004	0.996	0.000
R20.2 Paraesthesia of skin	0.004	0.996	0.000
H04 Disorders of lachrymal system	0.000	0.996	0.004
U88 Agent resistant to multiple antibiotics	0.000	0.996	0.004
H04.4 Chronic inflammation of lachrymal passages	0.000	0.996	0.004
S82.40 Fracture of fibula alone (closed)	0.004	0.996	0.000
M06.8 Other specified rheumatoid arthritis	0.004	0.996	0.000
K62.9 Disease of anus and rectum, unspecified	0.004	0.996	0.000
T39.1 4-Aminophenol derivatives	0.004	0.996	0.000
C22.1 Intrahepatic bile duct carcinoma	0.000	0.996	0.004
Y83.9 Surgical procedure, unspecified	0.004	0.996	0.000
I34.1 Mitral (valve) prolapse	0.000	0.996	0.004
S82.30 Fracture of lower end of tibia (closed)	0.004	0.996	0.000
M71.29 Synovial cyst of popliteal space [Baker]-Site unspec	0.003	0.996	0.000
M71.28 Synovial cyst of popliteal space [Baker]-Other	0.003	0.996	0.000
M71.27 Synovial cyst of popliteal space [Baker]-Ankle/Foot	0.003	0.996	0.000
M71.25 Synovial cyst of popliteal space [Baker]-Pelvic/Thigh	0.003	0.996	0.000
M71.24 Synovial cyst of popliteal space [Baker]-Hand	0.003	0.996	0.000
M71.23 Synovial cyst of popliteal space [Baker]-Forearm	0.003	0.996	0.000
M71.22 Synovial cyst of popliteal space [Baker]-Upper arm	0.003	0.996	0.000
M71.21 Synovial cyst of popliteal space [Baker]-Shldr region	0.003	0.996	0.000
M71.20 Synovial cyst of popliteal space [Baker]-Mult sites	0.003	0.996	0.000
K62.3 Rectal prolapse	0.004	0.996	0.000
R40.2 Coma, unspecified	0.000	0.996	0.004
M06.2 Rheumatoid bursitis	0.003	0.996	0.000
M06.1 Adult-onset Still's disease	0.003	0.996	0.000
M06.4 Inflammatory polyarthropathy	0.003	0.997	0.000
C32.0 Glottis	0.003	0.997	0.000
C32.1 Supraglottis	0.003	0.997	0.000
G95.9 Disease of spinal cord, unspecified	0.003	0.997	0.000
H53.0 Amblyopia ex anopsia	0.003	0.997	0.000
C90.3 Solitary plasmacytoma	0.003	0.997	0.000
C90.1 Plasma cell leukaemia	0.003	0.997	0.000
H04.5 Stenosis and insufficiency of lachrymal passages	0.000	0.997	0.003
G93.3 Postviral fatigue syndrome	0.003	0.997	0.000
K62.8 Other specified diseases of anus and rectum	0.003	0.997	0.000
G95 Other diseases of spinal cord	0.003	0.997	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.003	0.997	0.000
K62 Other diseases of anus and rectum	0.003	0.997	0.000
Q50-Q56 Congenital malformations of genital organs	0.003	0.997	0.000
G95.8 Other specified diseases of spinal cord	0.003	0.997	0.000
Z90.3 Acquired absence of part of stomach	0.003	0.997	0.001
M48.09 Spinal stenosis (Site unspecified)	0.000	0.997	0.003
G93.8 Other specified disorders of brain	0.000	0.997	0.003
M77.0 Medial epicondylitis	0.003	0.997	0.000
I30.9 Acute pericarditis, unspecified	0.000	0.997	0.003
G93.9 Disorder of brain, unspecified	0.003	0.997	0.000
Q51 Congenital malformations of uterus and cervix	0.003	0.997	0.000
Z88.9 Personal history of allergy to unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.003	0.997	0.000
H04.6 Other changes in lachrymal passages	0.000	0.997	0.003
Q55 Other congenital malformations of male genital organs	0.003	0.997	0.000
G95.1 Vascular myelopathies	0.003	0.997	0.000
H04.0 Dacryoadenitis	0.000	0.997	0.003
I61.5 Intracerebral haemorrhage, intraventricular	0.003	0.997	0.000
M06.40 Inflammatory polyarthropathy (Multiple sites)	0.003	0.997	0.000
H04.8 Other disorders of lachrymal system	0.000	0.997	0.003
M71 Other bursopathies	0.003	0.997	0.000
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.003	0.997	0.000
M06.88 Other specified rheumatoid arthritis (Other)	0.003	0.997	0.000
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.003	0.997	0.000
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.003	0.997	0.000
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.003	0.997	0.000
M06.84 Other specified rheumatoid arthritis (Hand)	0.003	0.997	0.000
M06.83 Other specified rheumatoid arthritis (Forearm)	0.003	0.997	0.000
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.003	0.997	0.000
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.003	0.997	0.000
S82.3 Fracture of lower end of tibia	0.003	0.997	0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.003	0.997	0.000
Q12.0 Congenital cataract	0.003	0.997	0.000
G91.2 Normal-pressure hydrocephalus	0.003	0.997	0.000
J34.0 Abscess, furuncle and carbuncle of nose	0.000	0.997	0.003
Q12 Congenital lens malformations	0.003	0.997	0.000
Q35-Q37 Cleft lip and cleft palate	0.003	0.997	0.000
M06.19 Adult-onset Still's disease (Site unspecified)	0.003	0.997	0.000
M06.18 Adult-onset Still's disease (Other)	0.003	0.997	0.000
M06.17 Adult-onset Still's disease (Ankle and foot)	0.003	0.997	0.000
M06.16 Adult-onset Still's disease (Lower leg)	0.003	0.997	0.000
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.003	0.997	0.000
M06.14 Adult-onset Still's disease (Hand)	0.003	0.997	0.000
M06.13 Adult-onset Still's disease (Forearm)	0.003	0.997	0.000
M06.12 Adult-onset Still's disease (Upper arm)	0.003	0.997	0.000
M06.11 Adult-onset Still's disease (Shoulder region)	0.003	0.997	0.000
M06.10 Adult-onset Still's disease (Multiple sites)	0.003	0.997	0.000
M06.29 Rheumatoid bursitis (Site unspecified)	0.003	0.997	0.000
M06.28 Rheumatoid bursitis (Other)	0.003	0.997	0.000
M06.27 Rheumatoid bursitis (Ankle and foot)	0.003	0.997	0.000
M06.26 Rheumatoid bursitis (Lower leg)	0.003	0.997	0.000
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.003	0.997	0.000
M06.24 Rheumatoid bursitis (Hand)	0.003	0.997	0.000
M06.23 Rheumatoid bursitis (Forearm)	0.003	0.997	0.000
M06.22 Rheumatoid bursitis (Upper arm)	0.003	0.997	0.000
M06.21 Rheumatoid bursitis (Shoulder region)	0.003	0.997	0.000
M06.20 Rheumatoid bursitis (Multiple sites)	0.003	0.997	0.000
Q55.0 Absence and aplasia of testis	0.003	0.997	0.000
G91 Hydrocephalus	0.003	0.997	0.000
Q38-Q45 Other congenital malformations of the digestive system	0.003	0.997	0.000
H04.9 Disorder of lachrymal system, unspecified	0.000	0.997	0.003
H04.3 Acute and unspecified inflammation of lachrymal passages	0.000	0.997	0.003
M06.48 Inflammatory polyarthropathy (Other)	0.003	0.997	0.000
M06.47 Inflammatory polyarthropathy (Ankle and foot)	0.003	0.997	0.000
M06.46 Inflammatory polyarthropathy (Lower leg)	0.003	0.997	0.000
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)	0.003	0.997	0.000
M06.44 Inflammatory polyarthropathy (Hand)	0.003	0.997	0.000
M06.43 Inflammatory polyarthropathy (Forearm)	0.003	0.997	0.000
M06.42 Inflammatory polyarthropathy (Upper arm)	0.003	0.997	0.000
M06.41 Inflammatory polyarthropathy (Shoulder region)	0.003	0.997	0.000
B02.3 Zoster ocular disease	0.000	0.997	0.003
Q51.3 Bicornate uterus	0.003	0.997	0.000
Q39 Congenital malformations of oesophagus	0.003	0.997	0.000
M06.3 Rheumatoid nodule	0.003	0.997	0.000
O42.9 Premature rupture of membranes, unspecified	0.000	0.997	0.003
G95.0 Syringomyelia and syringobulbia	0.003	0.997	0.000
O90.8 Other complications of the puerperium, not elsewhere classified	0.000	0.997	0.003
Q39.6 Diverticulum of oesophagus	0.003	0.997	0.000
G91.0 Communicating hydrocephalus	0.003	0.997	0.000
S82.31 Fracture of lower end of tibia (open)	0.003	0.997	0.000
M06.0 Seronegative rheumatoid arthritis	0.003	0.997	0.000
Q51.2 Other doubling of uterus	0.003	0.997	0.000
Q55.6 Other congenital malformations of penis	0.003	0.997	0.000
S82.4 Fracture of fibula alone	0.003	0.997	0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.003	0.997	0.000
Q30-Q34 Congenital malformations of the respiratory system	0.003	0.997	0.000
H53 Visual disturbances	0.003	0.997	0.000
Q52 Other congenital malformations of female genitalia	0.003	0.997	0.000
G96.1 Disorders of meninges, not elsewhere classified	0.003	0.997	0.000
Q51.8 Other congenital malformations of uterus and cervix	0.003	0.997	0.000
K60.1 Chronic anal fissure	0.003	0.997	0.000
E80.4 Gilbert's syndrome	0.000	0.997	0.003
Q56 Indeterminate sex and pseudohermaphroditism	0.002	0.997	0.000
Q53 Undescended testicle	0.002	0.997	0.000
G80.9 Infantile cerebral palsy, unspecified	0.003	0.997	0.000
G80.8 Other infantile cerebral palsy	0.002	0.997	0.000
L40.9 Psoriasis, unspecified	0.003	0.997	0.000
M71.9 Bursopathy, unspecified	0.002	0.997	0.000
M77.09 Medial epicondylitis (Site unspecified)	0.002	0.997	0.000
M77.08 Medial epicondylitis-Other	0.002	0.997	0.000
M77.07 Medial epicondylitis-Ankle/Foot	0.002	0.997	0.000
M77.06 Medial epicondylitis (Lower leg)	0.002	0.997	0.000
M77.05 Medial epicondylitis (Pelvic region and thigh)	0.002	0.997	0.000
M77.04 Medial epicondylitis-Hand	0.002	0.997	0.000
M77.03 Medial epicondylitis-Forearm	0.002	0.997	0.000
M77.01 Medial epicondylitis-Shldr region	0.002	0.997	0.000
M77.00 Medial epicondylitis (Multiple sites)	0.002	0.997	0.000
G91.8 Other hydrocephalus	0.002	0.997	0.000
K62.1 Rectal polyp	0.003	0.997	0.000
Q44 Congenital malformations of gallbladder, bile ducts and liver	0.002	0.997	0.000
B00.5 Herpesviral ocular disease	0.000	0.997	0.002
H53.4 Visual field defects	0.002	0.997	0.000
Q51.9 Congenital malformation of uterus and cervix, unspecified	0.002	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations